Target intelligence / Profile preview

Gram-negative bacterial outer membrane lipids (Lipid A and phospholipids)

Molecular classification
Bacterial cell wall component, Glycolipid, Phospholipid
01

Overview

The outer membrane of Gram-negative bacteria is an asymmetric bilayer that functions as a selective permeability barrier, protecting the cell from environmental threats and antibiotics (Nikaido, 2003). The outer leaflet is predominantly composed of lipopolysaccharide (LPS), with Lipid A serving as the hydrophobic anchor and the primary mediator of endotoxic activity (Raetz & Whitfield, 2002). The inner leaflet consists of phospholipids, primarily phosphatidylethanolamine and phosphatidylglycerol, which maintain membrane fluidity and structural stability. During infection, Lipid A is recognized by the host's TLR4/MD-2 receptor complex, triggering a pro-inflammatory cytokine cascade that can escalate to life-threatening sepsis or septic shock (Park & Lee, 2013). Drugs such as polymyxins target this structure by electrostatically interacting with the negatively charged phosphate groups on Lipid A and phospholipids (Velkov et al., 2013). This interaction displaces stabilizing divalent cations like Mg2+ and Ca2+, leading to membrane disruption, leakage of cytoplasmic contents, and bacterial cell death.

Other names
Lipid ALipopolysaccharide componentEndotoxinOuter membrane phospholipidsGram-negative envelope lipids
02

Mechanism of action

Cationic antibiotics like polymyxins bind to the negatively charged phosphate groups of Lipid A and phospholipids, displacing divalent cations (Mg2+ and Ca2+) that stabilize the membrane (Velkov et al., 2013). This leads to increased membrane permeability, loss of periplasmic proteins, and physical disruption of the cell envelope (Nikaido, 2003). Additionally, binding to Lipid A neutralizes its ability to trigger TLR4-mediated inflammatory responses (Park & Lee, 2013).

03

Biological functions

Structural integrityPermeability barrierImmune activationEndotoxin activity
04

Disease associations

InfectionSepsisSeptic shock
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reactionEmergence of colistin resistance (mcr genes)
06

Interacting drugs

Polymyxin B

5 more in the full profile.

07

Biomarkers

Endotoxin activity assay (EAA)ProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane lipids (Lipid A and phospholipids).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane lipids (Lipid A and phospholipids).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call